Literature DB >> 20617900

CD4(+) regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infection.

Angela M Green1, Joshua T Mattila, Carolyn L Bigbee, Kale S Bongers, P Ling Lin, Joanne L Flynn.   

Abstract

BACKGROUND: Mycobacterium tuberculosis infection in humans results in either latent infection or active tuberculosis. We sought to determine whether a higher frequency of regulatory T (T(reg)) cells predispose an individual toward active disease or whether T(reg) cells develop in response to active disease.
METHODS: In cynomolgus macaques infected with a low dose of M. tuberculosis, approximately 50% develop primary tuberculosis, and approximately 50% become latently infected. Forty-one animals were monitored for 6-8 months to assess the correlation of the frequency of Foxp3(+) cells in peripheral blood and airways with the outcome of infection.
RESULTS: In all animals, the frequency of T(reg) cells (CD4(+)Foxp3(+)) in peripheral blood rapidly decreased and simultaneously increased in the airways. Latently infected monkeys had a significantly higher frequency of T(reg) cells in peripheral blood before infection and during early infection, compared with monkeys that developed active disease. Monkeys with active disease experienced increased frequencies of T(reg) cells among peripheral blood mononuclear cells as they developed disease.
CONCLUSIONS: Our data suggest that increased frequencies of T(reg) cells in active disease occur in response to increased inflammation rather than act as a causative factor in progression to active disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20617900      PMCID: PMC3683560          DOI: 10.1086/654896

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

1.  Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3.

Authors:  Sarah E Allan; George X Song-Zhao; Thomas Abraham; Alicia N McMurchy; Megan K Levings
Journal:  Eur J Immunol       Date:  2008-12       Impact factor: 5.532

2.  CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.

Authors:  Xinchun Chen; Boping Zhou; Meizhong Li; Qunyi Deng; Xueqiong Wu; Xiaohua Le; Chi Wu; Nicolas Larmonier; Wei Zhang; Hongmei Zhang; Huosheng Wang; Emmanuel Katsanis
Journal:  Clin Immunol       Date:  2007-01-17       Impact factor: 3.969

Review 3.  Role of endogenous and induced regulatory T cells during infections.

Authors:  Elizabeth Wohlfert; Yasmine Belkaid
Journal:  J Clin Immunol       Date:  2008-09-23       Impact factor: 8.317

4.  Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model.

Authors:  Philana Ling Lin; Mark Rodgers; Le'kneitah Smith; Matthew Bigbee; Amy Myers; Carolyn Bigbee; Ion Chiosea; Saverio V Capuano; Carl Fuhrman; Edwin Klein; JoAnne L Flynn
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

5.  In vitro expansion of CD4+CD25highFOXP3+CD127low/- regulatory T cells from peripheral blood lymphocytes of healthy Mycobacterium tuberculosis-infected humans.

Authors:  Jean-Michel Hougardy; Virginie Verscheure; Camille Locht; Françoise Mascart
Journal:  Microbes Infect       Date:  2007-06-30       Impact factor: 2.700

Review 6.  T-regulatory lymphocytes and chronic viral hepatitis.

Authors:  Simon M Rushbrook; Matthew Hoare; Graeme J M Alexander
Journal:  Expert Opin Biol Ther       Date:  2007-11       Impact factor: 4.388

7.  Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis.

Authors:  T Chiacchio; R Casetti; O Butera; V Vanini; S Carrara; E Girardi; D Di Mitri; L Battistini; F Martini; G Borsellino; D Goletti
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

8.  Regulatory T cells depress immune responses to protective antigens in active tuberculosis.

Authors:  Jean-Michel Hougardy; Sammy Place; Marc Hildebrand; Annie Drowart; Anne-Sophie Debrie; Camille Locht; Francoise Mascart
Journal:  Am J Respir Crit Care Med       Date:  2007-05-31       Impact factor: 21.405

9.  FOXP3 gene expression in a tuberculosis case contact study.

Authors:  S Burl; P C Hill; D J Jeffries; M J Holland; A Fox; M D Lugos; R A Adegbola; G A Rook; A Zumla; K P W J McAdam; R H Brookes
Journal:  Clin Exp Immunol       Date:  2007-04-26       Impact factor: 4.330

10.  Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis.

Authors:  James P Scott-Browne; Shahin Shafiani; Glady's Tucker-Heard; Kumiko Ishida-Tsubota; Jason D Fontenot; Alexander Y Rudensky; Michael J Bevan; Kevin B Urdahl
Journal:  J Exp Med       Date:  2007-08-20       Impact factor: 14.307

View more
  51 in total

1.  The Mycobacterium tuberculosis stress response factor SigH is required for bacterial burden as well as immunopathology in primate lungs.

Authors:  Smriti Mehra; Nadia A Golden; Kerstan Stuckey; Peter J Didier; Lara A Doyle; Kasi E Russell-Lodrigue; Chie Sugimoto; Atsuhiko Hasegawa; Satheesh K Sivasubramani; Chad J Roy; Xavier Alvarez; Marcelo J Kuroda; James L Blanchard; Andrew A Lackner; Deepak Kaushal
Journal:  J Infect Dis       Date:  2012-03-07       Impact factor: 5.226

2.  CD4 T cell depletion exacerbates acute Mycobacterium tuberculosis while reactivation of latent infection is dependent on severity of tissue depletion in cynomolgus macaques.

Authors:  Philana Ling Lin; Tara Rutledge; Angela M Green; Matthew Bigbee; Carl Fuhrman; Edwin Klein; JoAnne L Flynn
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-04       Impact factor: 2.205

Review 3.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

Review 4.  Development of new vaccines and drugs for TB: limitations and potential strategic errors.

Authors:  Ian M Orme
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

Review 5.  Latent tuberculosis: what the host "sees"?

Authors:  Hannah P Gideon; JoAnne L Flynn
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

Review 6.  Clinical immunology and multiplex biomarkers of human tuberculosis.

Authors:  Gerhard Walzl; Mariëlle C Haks; Simone A Joosten; Léanie Kleynhans; Katharina Ronacher; Tom H M Ottenhoff
Journal:  Cold Spring Harb Perspect Med       Date:  2014-12-04       Impact factor: 6.915

Review 7.  T regulatory cells: Achilles' heel of Mycobacterium tuberculosis infection?

Authors:  Om Parkash; Sonali Agrawal; M Madhan Kumar
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

8.  A review of computational and mathematical modeling contributions to our understanding of Mycobacterium tuberculosis within-host infection and treatment.

Authors:  Denise Kirschner; Elsje Pienaar; Simeone Marino; Jennifer J Linderman
Journal:  Curr Opin Syst Biol       Date:  2017-05-22

Review 9.  The non-human primate model of tuberculosis.

Authors:  D Kaushal; S Mehra; P J Didier; A A Lackner
Journal:  J Med Primatol       Date:  2012-03-20       Impact factor: 0.667

Review 10.  CD8 T cells and Mycobacterium tuberculosis infection.

Authors:  Philana Ling Lin; JoAnne L Flynn
Journal:  Semin Immunopathol       Date:  2015-04-28       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.